JUN and esophageal squamous cell carcinoma: Collectively, our findings highlight the oncogenic role of NUAK1 in promoting ESCC cell migration, invasion and metastasis through activating JNK/c-Jun/Slug signaling, implicating that NUAK1 is a potential therapeutic target for the metastatic ESCC.